Related Experiment Video
Updated: Apr 5, 2026
08:26
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
2.9K
[OSTEOPOROSIS AND PERSONALIZED MEDICINE]
Revue Medicale De Liege
|August 20, 2015
Summary
Personalized medicine for osteoporosis is emerging. The FRAX® tool aids in assessing 10-year fracture risk, guiding treatment decisions for high-risk patients.
Area of Science:
- Gerontology
- Pharmacology
- Genetics
Context:
- Osteoporosis management is evolving towards personalized medicine.
- The FRAX® algorithm is a key tool for assessing fracture risk.
- Current genetic profiling for osteoporosis prognosis is inconclusive.
Purpose:
- To highlight the role of the FRAX® algorithm in personalized osteoporosis treatment.
- To emphasize the importance of patient preferences in therapeutic adherence.
- To discuss the current limitations in genetic profiling for osteoporosis.
Summary:
- The FRAX® tool provides a 10-year fracture risk assessment, improving treatment decisions for osteoporosis.
- It assists in selecting pharmacologic treatments, particularly for non-vertebral fractures in high-risk individuals.
- Incorporating patient preferences enhances treatment adherence, efficacy, and efficiency.
Impact:
- Facilitates personalized treatment strategies for osteoporosis.
- Improves patient adherence and treatment outcomes.
- Highlights areas for future research in genetic profiling for osteoporosis.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
02:50Combination Therapies and Personalized Medicine
1.8K
1.8K
01:29Pharmacogenetics and Pharmacogenomics: Overview
152
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
152
01:31Osteoclasts in Bone Remodeling
4.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.8K
01:29Bone Disorders
8.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.0K
01:29Pharmacogenomics: Identification of New Drug Targets
86
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
86